Dashboard
Manage Tickers

IONS


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

rubrik-reports-q2-results-joins-ionis-pharmaceuticals-hewlett-packard-enterprise-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session
Rubrik Reports Q2 Results, Joins Ionis Pha...
09/10/2024 12:32:24

why-oracle-shares-are-trading-higher-by-around-9-here-are-20-stocks-moving-premarket
Why Oracle Shares Are Trading Higher By Ar...
09/10/2024 10:41:15

reported-earlier-ionis-prices-5003m-public-offering-of-115m-common-shares-at-4350share
Reported Earlier, Ionis Prices $500.3M Pub...
09/10/2024 07:35:14

Ionis intends to use the net proceeds from the offering to fund its independent commercial launches, late-stage clinical progra...

ionis-pharmaceuticals-announces-500m-public-offering-of-common-stock
Ionis Pharmaceuticals Announces $500M Publ...
09/09/2024 20:20:44

what-14-analyst-ratings-have-to-say-about-ionis-pharmaceuticals
What 14 Analyst Ratings Have To Say About ...
08/26/2024 15:00:53

jp-morgan-maintains-neutral-on-ionis-pharmaceuticals-raises-price-target-to-55
JP Morgan Maintains Neutral on Ionis Pharm...
08/26/2024 14:46:47

JP Morgan analyst Jessica Fye maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Neutral and raises the price target from ...

guggenheim-maintains-buy-on-ionis-pharmaceuticals-raises-price-target-to-70
Guggenheim Maintains Buy on Ionis Pharmace...
08/02/2024 19:27:39

Guggenheim analyst Debjit Chattopadhyay maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Buy and raises the price target...

goldman-sachs-maintains-sell-on-ionis-pharmaceuticals-raises-price-target-to-37
Goldman Sachs Maintains Sell on Ionis Phar...
08/02/2024 16:37:12

Goldman Sachs analyst Salveen Richter maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Sell and raises the price target ...

barclays-maintains-equal-weight-on-ionis-pharmaceuticals-raises-price-target-to-51
Barclays Maintains Equal-Weight on Ionis P...
08/02/2024 15:04:07

Barclays analyst Gena Wang maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Equal-Weight and raises the price target fro...

12-analysts-have-this-to-say-about-ionis-pharmaceuticals
12 Analysts Have This To Say About Ionis P...
08/02/2024 12:00:30

needham-reiterates-buy-on-ionis-pharmaceuticals-maintains-60-price-target
Needham Reiterates Buy on Ionis Pharmaceut...
08/02/2024 10:15:43

Needham analyst Joseph Stringer reiterates Ionis Pharmaceuticals (NASDAQ:IONS) with a Buy and maintains $60 price target.

bmo-capital-downgrades-ionis-pharmaceuticals-to-market-perform-lowers-price-target-to-60
BMO Capital Downgrades Ionis Pharmaceutica...
08/02/2024 09:15:41

BMO Capital analyst Kostas Biliouris downgrades Ionis Pharmaceuticals (NASDAQ:IONS) from Outperform to Market Perform and lo...

ionis-pharmaceuticals-q2-2024-adj-eps-024-beats-092-estimate-sales-225000m-beat-150073m-estimate
Ionis Pharmaceuticals Q2 2024 Adj. EPS $(0...
08/01/2024 11:37:34

Core News & Articles
Alcyone Therapeutics Announces Continued E...
07/31/2024 13:08:46

Alcyone's ThecaFlex is an implantable medical device under investigation for routine subcutaneous administration of therape...

leerink-partners-upgrades-ionis-pharmaceuticals-to-outperform-raises-price-target-to-62
Leerink Partners Upgrades Ionis Pharmaceut...
07/24/2024 10:47:12

Leerink Partners analyst Mani Foroohar upgrades Ionis Pharmaceuticals (NASDAQ:IONS) from Market Perform to Outperform and ra...

td-cowen-maintains-buy-on-ionis-pharmaceuticals-raises-price-target-to-59
TD Cowen Maintains Buy on Ionis Pharmaceut...
07/23/2024 17:04:00

TD Cowen analyst Yaron Werber maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Buy and raises the price target from $54 ...

b-of-a-securities-maintains-buy-on-ionis-pharmaceuticals-raises-price-target-to-68
B of A Securities Maintains Buy on Ionis P...
07/23/2024 13:39:22

B of A Securities analyst Jason Gerberry maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Buy and raises the price targe...

needham-reiterates-buy-on-ionis-pharmaceuticals-maintains-60-price-target
Needham Reiterates Buy on Ionis Pharmaceut...
07/22/2024 18:35:10

Needham analyst Joseph Stringer reiterates Ionis Pharmaceuticals (NASDAQ:IONS) with a Buy and maintains $60 price target.

ionis-rare-development-disorder-drug-candidate-could-be-differentiated-from-peer-ultragenyx-analyst
Ionis' Rare Development Disorder Drug Cand...
07/22/2024 17:04:26

Ionis Pharmaceuticals releases positive results from Phase 1/2 study of ION582 for Angelman syndrome, showing consistent clinic...

ionis-pharmaceuticals-announces-phase-12-results-for-angelman-syndrome-treatment
Ionis Pharmaceuticals Announces Phase 1/2 ...
07/22/2024 11:02:22

 Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) today announced positive results from the completed multiple ascending dose (MAD) po...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION